These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 10335480

  • 21. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S, Kalasapudi RS, Rao TD, Thirumala S.
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [Abstract] [Full Text] [Related]

  • 22. Cervical cancer vaccines: recent advances in HPV research.
    Eiben GL, da Silva DM, Fausch SC, Le Poole IC, Nishimura MI, Kast WM.
    Viral Immunol; 2003; 16(2):111-21. PubMed ID: 12828864
    [Abstract] [Full Text] [Related]

  • 23. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
    Mora-García ML, Monroy-García A.
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
    [Abstract] [Full Text] [Related]

  • 24. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
    Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.
    Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus vaccines and adolescents.
    Kahn JA, Bernstein DI.
    Curr Opin Obstet Gynecol; 2005 Oct; 17(5):476-82. PubMed ID: 16141761
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR.
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Therapeutic vaccines for high-risk HPV-associated diseases.
    Chabeda A, Yanez RJR, Lamprecht R, Meyers AE, Rybicki EP, Hitzeroth II.
    Papillomavirus Res; 2018 Jun; 5():46-58. PubMed ID: 29277575
    [Abstract] [Full Text] [Related]

  • 38. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
    Valdespino-Gómez VM.
    Cir Cir; 2005 Jun; 73(1):57-69. PubMed ID: 15888272
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Papillomavirus vaccines in clinical trials.
    Galloway DA.
    Lancet Infect Dis; 2003 Aug; 3(8):469-75. PubMed ID: 12901889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.